An updated patent review of glutaminase inhibitors (2019-2022)
{{output}}
Introduction: Kidney-type glutaminase (GLS1), a key enzyme controlling the hydrolysis of glutamine to glutamate to resolve the 'glutamine addiction' of cancer cells, has been shown to play a central role in supporting cancer grow... ...